Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Abstract Text:

Susan M Paddock,Maria O Edelen,Suzanne L Wenzel,Patricia Ebener,Wallace Mandell,James Dahl,

The Dimensions of Change Instrument (DCI) measures treatment process in residential therapeutic community (TC) settings. It summarizes eight factors of treatment process from a client perspective. We present evidence of the reliability of the DCI for assessing both adult (N = 519) and adolescent (N = 474) client perceptions of treatment process. The DCI factors significantly increase over time, with increases consistently seen across all DCI factors for adults. We highlight areas for future DCI modifications to broaden its applicability to adolescents. Our findings show that clinicians can use the DCI to evaluate adult client progress and target areas for improving quality of care.

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Publishing Authors By Initials

SM Paddock,MO Edelen,SL Wenzel,P Ebener,W Mandell,J Dahl,

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The American journal of drug and alcohol abuse

VOLUME: 33

Page Numbers: 537-46

Journal Abbreviation:

ISSN: 0095-2990

DAY: 3

MONTH: 12

YEAR: 2007

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7502510

Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: therapy

Chemical & Substance for Abstract: Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).

AFFILIATION: RAND Corporation, Santa Monica, California 90407-2138, USA. paddock@rand.org

Country: United States

AGENCY: United States NIDA

GRANT: R01DA14969

ACRONYM: DA

MEDLINETA: Am J Drug Alcohol Abuse

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Measuring changes in client-level treatment process in the therapeutic community TC with the Dimensions of Change Instrument DCI Related Publications

• A controlled study of job strain in primary-treated cancer patients without metastases.
• A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production.
• A novel splice site mutation in EYA4 causes DFNA10 hearing loss.
• A prospective study of patterns of fatigue in multiple sclerosis.
• Adverse patient reactions during orthodontic treatment with fixed appliances.
• Affect regulation, brain development, and behavioral/emotional health in adolescence.
• Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
• Alterations in reward-related decision making in boys with recent and future depression.
• Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden.
• Attitudes and practices of pediatric oncology providers regarding fertility issues.
• CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
• Chop it, ChIP it, check it: the current status of chromatin immunoprecipitation.
• Concerns about infertility risks among pediatric oncology patients and their parents.
• HEMA reduces cell proliferation and induces apoptosis in vitro.
• In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?-Response.
• Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
• Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters.
• Molecular characterization of a novel X-linked syndrome involving developmental delay and deafness.
• Nanosized (mu12-Pt)Pd164-xPtx(CO)72(PPh3)20 (x approximately 7) containing Pt-centered four-shell 165-atom Pd-Pt core with unprecedented intershell bridging carbonyl ligands: comparative analysis of icosahedral shell-growth patterns with geometrically rel
• Neural systems of positive affect: relevance to understanding child and adolescent depression?
• Resilience among children and adolescents at risk for depression: Mediation and moderation across social and neurobiological contexts.
• Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
• Sleep and the developing brain.
• Sleeplessness and aggression in youth.
• The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.
• Vectors using the phospho-alpha-(1,1)-glucosidase-encoding gene treA of Bacillus subtilis as a reporter.
• Vincent's infection.
• Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress.
• [Adjuvant chemotherapy for colon cancer.]
• [In Process Citation]